GoodRx Holdings Inc

GoodRx Holdings Inc(GDRX)の株式分析

$3.530

+0.020 (+0.57%)終値時点

Loading chart…
High
3.595
Open
3.500
VWAP
3.54
Vol
1.00M
Mkt Cap
2.89B
Low
3.500
Amount
3.55M
EV/EBITDA, TTM
7.67

GoodRx Holdings, Inc. is a platform for medication savings in the United States, used by consumers and healthcare professionals. The Company connects consumers, healthcare professionals, payers, pharmacy benefit managers (PBMs), pharma manufacturers, and retail pharmacies to make saving on medications easier. The Company's offerings include prescription marketplace and pharma manufacturer solutions. Its prescription marketplace consists of its prescription transactions offering and its supplemental subscription and telehealth offerings. Through its GoodRx Care platform, the Company offers consumers access to telehealth visits on a cash-pay basis outside of insurance. The Company partners with pharma manufacturers to advertise and integrate their affordable solutions into its platform. These solutions, provided by pharma manufacturers, include co-pay cards, patient assistance programs, care portals, and other savings options to ensure consumers can access their medications.

AI analysis of GoodRx Holdings Inc (GDRX)

buy

GoodRx Holdings Inc (GDRX) appears to be a good buy right now, trading at $3.53, which is below the average analyst target price of $4.50. The stock has shown a positive trend with a 20-day change of +14.98% and a year-to-date change of +28.36%. Although the RSI is at 48.888, indicating a neutral momentum, the forward P/E ratio of 5.4407 suggests that the stock is undervalued compared to its earnings potential. The main risk is the significant decline in Q2 earnings, reporting a net income of $8.54 million, down from $12.84 million last year, which may impact investor confidence.

バリュエーション指標

The current forward P/E ratio for GoodRx Holdings Inc (GDRX) is 5.44, compared to its 5-year average forward P/E of 44.51.

Forward P/E

Fair
5Y Average P/E
44.51
Current P/E
5.44
割高
654.78
割安
-565.75

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
14.31
Current EV/EBITDA
7.67
割高
28.40
割安
0.22

Forward P/S

Fair
5Y Average P/S
4.10
Current P/S
1.43
割高
8.47
割安
-0.26

Alphio AI Price Scenarios for GDRX

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%GDRX

$4.23

シナリオ価格

B

Base

Base · 50%GDRX

$3.42

シナリオ価格

B

Bear

Bear · 25%GDRX

$3.21

シナリオ価格

Whales holding GDRX

T

TCMI Inc.

+ HoldingGDRX

+8.39%

3M Return

S

Silver Lake Technology Management, L.L.C.

+ HoldingGDRX

+1.77%

3M Return

イベントタイムライン

2026-08-05 (ET)

17:31:00

GoodRx Q2 Revenue $200.4M, Exceeds Consensus

17:30:00

Raises FY26 Adjusted EBITDA Outlook to $240M-$250M

2026-05-27 (ET)

09:10:00

GoodRx Launches GoodRx Companion Subscription at $14.99 per Month

2026-05-06 (ET)

17:10:00

GoodRx Q1 Revenue $194M Beats Expectations

17:10:00

Raises FY26 Adjusted EBITDA Outlook to Over $235M

ニュース

GDRX FAQ — answered by Alphio AI

GoodRx Holdings, Inc. is a platform for medication savings in the United States, used by consumers and healthcare professionals. The Company connects consumers, healthcare professionals, payers, pharmacy benefit managers (PBMs), pharma manufacturers, and retail pharmacies to make saving on medications easier. The Company's offerings include prescription marketplace and pharma manufacturer solutions. Its prescription marketplace consists of its prescription transactions offering and its supplemental subscription and telehealth offerings. Through its GoodRx Care platform, the Company offers consumers access to telehealth visits on a cash-pay basis outside of insurance. The Company partners with pharma manufacturers to advertise and integrate their affordable solutions into its platform. These solutions, provided by pharma manufacturers, include co-pay cards, patient assistance programs, care portals, and other savings options to ensure consumers can access their medications. It operates in the Technology sector (SERVICES-COMPUTER PROCESSING & DATA PREPARATION industry).

GoodRx Holdings Inc (GDRX) appears to be a good buy right now, trading at $3.53, which is below the average analyst target price of $4.50. The stock has shown a positive trend with a 20-day change of +14.98% and a year-to-date change of +28.36%. Although the RSI is at 48.888, indicating a neutral momentum, the forward P/E ratio of 5.4407 suggests that the stock is undervalued compared to its earnings potential. The main risk is the significant decline in Q2 earnings, reporting a net income of $8.54 million, down from $12.84 million last year, which may impact investor confidence.

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

無料で始める